1. Introduction {#sec0005}
===============

Phyllodes tumors are rare fibroepithelial tumors of the breast, accounting for less than one percent of all breast tumors \[[@bib0005], [@bib0010], [@bib0015]\]. Phyllodes tumors are divided into three categories: benign, borderline and malignant phyllodes with the majority of cases defined as benign \[[@bib0020]\]. It is unusual for a malignant phyllodes tumor to present in young patients \[[@bib0010]\]; for, the mean age of presentation of malignant Phyllodes tumor is 40 years \[[@bib0025]\]. Even though both breasts have the same propensity of phyllodes tumor occurrence, phyllodes tumors generally manifest as a rapidly growing single breast mass \[[@bib0030],[@bib0035]\] that is commonly located in the upper outer quadrant of the breast \[[@bib0040]\]. Multifocal or bilateral presentations of phyllodes tumors are uncommon and most often are asynchronous and cancerous \[[@bib0005]\].

As the surgical excision is the treatment of Phyllodes tumor with a safety margin of 1 cm mastectomy and conservative breast surgery are both valid options \[[@bib0045]\]. In addition, adjuvant radiotherapy is advised in cases of high malignancy and incomplete excisions. Younger age patients with sizable masses might also benefit from radiotherapy. Chemotherapy, however, has no significant effect on the treatment of Phyllodes tumors \[[@bib0045]\]. Phyllodes Tumor can reach huge dimensions. Local recurrence rates are related to tumor size. However, tumor size does not seem important in determining metastatic potential. Unlike epithelial breast cancers, Phyllodes tumors do not usually metastasis to axillary lymph nodes, and therefore, axillary dissection is not warranted in Phyllodes tumor unless there is proven metastasis \[[@bib0050]\]. An unusual case of phyllodes tumors is discussed here.

2. Case presentation {#sec0010}
====================

A 23-year-old woman with no known risk factors for breast and/or ovary cancer who had a fibroadenoma excision under local anesthesia in Jan 2019 was presented to our hospital because of left breast mass. The mass was first noticed in March 2019 and was increasing in size dramatically, growing from the breast towards the armpit over the next two months (see [Fig. A1](#fig0040){ref-type="fig"} in the Appendix A section for timeline). The fast-growing mass was deep, hard and minimally mobile. It was associated with skin redness and engorgement of the breast. There was no nipple discharge. There were no other masses noticed in the right breast or any other site ([Fig. 1](#fig0005){ref-type="fig"}). There were no systemic symptoms like fever, general weakness or change in body weight. By May 2019 the mass started to feel painful and the patient was unable to sleep without taking NSAIDs. Hence, the patient visited the surgery clinic. Upon physical exam, the young lady looked well, with stable vital signs. Her right breast showed longitudinal scar lateral to areola related to the previous excision of fibroadenoma. There were no palpable masses on the right side. The left breast was markedly enlarged, especially in the outer quadrant, with a small patch of skin discoloration (necrosis) measuring around 1 cm in the upper inner quadrant above the nipple. Many dilated superficial veins were seen, with no nipple discharge. On palpation of left breast, two masses were felt: one parenchymal measuring almost 10 × 8 cm, and the other deep between breast tissue and axilla (muscular) with ill-defined inner borders. Both masses were hard and immobile, and they were fixed to underlying structures. No palpable axillary lymph nodes were found.Fig. 1Picture showing pre-operative left Breast tumor.Fig. 1

The rest of her physical exam results were within normal limits. Her blood and laboratory results of complete blood count, kidney function tests, and liver function tests were all within normal limits.

Breast ultrasound and breast MRI were performed on the 11th of May 2019 and showed normal right breast and multiple left breast lesions. Lesions\' appearance was suggestive of bilobed/multifocal intra-parenchymal phyllodes tumor ([Fig. 2](#fig0010){ref-type="fig"}). A well-circumscribed mass located between the anterior chest wall and pectoralis major muscle was seen ([Fig. 3](#fig0015){ref-type="fig"}). The impression of a multifocal intra-parenchymal and sub-pectoral phyllodes tumor was concluded by MRI imaging ([Fig. 4](#fig0020){ref-type="fig"}). Histopathological study of left breast mass Tru-Cut biopsy performed on the 27th of May 2019 showed phyllodes tumor of borderline category: it featured an adequate sample of tissue with fibro-adenomatoid changes showing prominent stromal cellularity, occasional mitoses, and no apparent stromal atypia. A pan CT scan revealed no radiological evidence of distant metastatic disease.Fig. 2Breast MRI. Arrow pointing towards bilobed intra-parenchymal Phyllodes tumor.Fig. 2Fig. 3Breast MRI. Arrow pointing towards sub-pectoral Phyllodes tumor.Fig. 3Fig. 4Breast MRI. Multifocal intra-parenchymal and sub-pectoral phyllodes tumor.Green arrow points towards intra-parenchymal Phyllodes tumor, red arrow points towards sub-pectoral Phyllodes tumor.Fig. 4

The following surgery was performed on the 3rd of June 2019: left breast nipple-sparing mastectomy with the excision of a retro-pectoral mass ([Fig. 5](#fig0025){ref-type="fig"}) and immediate breast reconstruction using a submuscular Silicone Implant (305 cc Mentor™ anatomical implant) & Ti-Loop™ Mesh.Fig. 5Intraoperative picture of the retro-pectoral mass after complete excision.Fig. 5

Mastectomy specimen showed a 16 × 14 × 10 cm mass, comprised of two tumors, ([Fig. 6](#fig0030){ref-type="fig"}). First one is 8 × 7 × 6 cm, and the second one is 12.5 × 8 × 7.5 cm. Microscopic examination showed hypercellular stroma with atypia, the mitotic rate is high and about more than \>10 mitotic figure per 10 high per field with atypical mitosis, with marked stromal overgrowth with focal osteoid matrix identified. The densely packed anaplastic stromal cells are infiltrating into adjacent borders, representing a malignant phyllodes tumor, that is incompletely excised. The 1st tumor is reaching the anterior and lateral margins (subareolar/cutaneous margin) 0.6 cm superior margin, posterior and medial margins are free (more than 1 cm away). The second tumor is also reaching the anterior margin (subareolar/cutaneous margin), Posterior margin (chest wall) is 0.1 cm away, lateral and medial margins are free (more than 1 cm away). Both, Heterologous elements (osteoid) and stromal overgrowth are identified. Histopathology for retro-pectoral mass showed an 8 × 7 × 6 cm malignant phyllodes tumor that is excised with 0.1 cm superior margin and 0.2 cm for both lateral and medial margins.Fig. 6Mastectomy specimen with two intraparenchymal masses.Fig. 6

One-month post-operation and after full patient recovery ([Fig. 7](#fig0035){ref-type="fig"}), the patient was sent to a radiotherapy unit at another medical center for assessment and consultation. The patient was planned for adjuvant radiotherapy to the chest wall: 2.67 Gy over 33 sessions starting on the 16th of September and finishing by the 3rd of November 2019.Fig. 7Post-operative Left Breast picture.Fig. 7

The patient is now scheduled for 6-month-interval follow-up for local recurrence and distant metastatic workup.

3. Discussion {#sec0015}
=============

The current report presented a case of malignant Phyllodes tumor that is exceptional in several aspects: age, multifocality and the extraordinary site of the tumor. Adding more complexity to the situation, patient refused the radical surgery of removing nipple areola complex.

Malignant phyllodes tumors are rare and peak usually in the fourth decade of life. However, it can occur at a younger age. Presentation of malignant Phyllodes tumor is uncommon at a young age. Only a few cases of malignant Phyllodes tumors in younger age groups were reported. About twenty cases of children of Phyllodes tumors have been previously reported \[[@bib0055], [@bib0060], [@bib0065], [@bib0070], [@bib0075], [@bib0080], [@bib0085], [@bib0090], [@bib0095]\]. Of those cases, only three were malignant \[[@bib0065],[@bib0090],[@bib0095]\]. For young women between 20--29 years old, a previous study by Abusalem and AlMasri \[[@bib0100]\] indicated that four out of 26 patients with Phyllodes tumors were in their twenties. Of those four, one had a malignant tumor. In addition, a recent study by Nguyen et al. \[[@bib0105]\] reported a high-grade malignant Phyllodes tumor in a 26-year-old female. Early diagnosis and initiation of appropriate treatment of Phyllodes tumors may lead to prevent metastasis and improve outcomes.

Phyllodes tumor is usually described by patients as a single fast-growing breast mass. Phyllodes tumor generally represents a single mass with well-defined borders \[[@bib0110]\]. In the case reported here, the presence of three masses increasing in size simultaneously in a short period indicates a unique presentation regarding multifocality.

To the best of our knowledge, cases of extra-parenchymal primary Phyllodes tumor of the breast have not been studied before. In this case report, the 23-year-old female had a unique presentation of a fast-growing Phyllodes tumor between the pectoralis major muscle and anterior chest wall, next to this fast-growing mass, two additional masses with almost the same size were found at the left breast intra-parenchymal area. All three masses were diagnosed later as Malignant Phyllodes tumors. Malignant Phyllodes tumors have the potential to distantly metastasize \[[@bib0115]\]. The presence of local extramammary Phyllodes tumor in the current case is not easy to understand or explain as it is the first time for a such presentation to be reported.

Complete surgical excision of Phyllodes tumor is the treatment of choice. Involved margins increase the risk for local recurrence. Conservative or radical surgeries are all valid options \[[@bib0120]\]. Phyllodes tumors are not more aggressive in younger women compared to older patients \[[@bib0125]\]. The patient in the current report refused any surgical intervention that would leave her with a deformity, including nipple-areola complex removal. She insisted on preserving her natural nipple and areola despite the presence of the tumor. Her young age, the stigma of nipple-areola complex removal and the psychological impact were given as reasons behind declining any surgery involving nipple-areola complex removal. The patient defended her decision to avoid redo surgery for complete excision depending on the available evidence that post-operation radiotherapy decreases local and systemic recurrence of the disease \[[@bib0045]\]. She also argued that even in cases of complete excision, local or distant recurrences are around 20 % for malignant Phyllodes \[[@bib0130]\]., The patient also expressed concern of misshapenness and lower self-esteem as an additional reason for refusing nipple areola complex removal. After completion of radiotherapy treatment, the patient is now scheduled for her 6-month-interval routine follow-up. The follow up will involve a general exam and detailed breast exam that will include chest CT scan as recommended by Tremblay-LeMay et al. \[[@bib0135]\].

4. Conclusion {#sec0020}
=============

Phyllodes tumors usually present in 35--55 years old female patients but should be suspected in any fast-growing breast mass, even in young age groups. Phyllodes Tumors are usually mono-focal and unilateral with multifocal cases being very rare. The current report is the first to include Sub-pectoral breast primary phyllodes tumor. Finally, in this case the patient preferred adjuvant radiotherapy to the nipple-areola complex and surrounding skin instead of surgical excision although results are oncologically inferior. Early diagnosis and initiation of appropriate treatment of Phyllodes tumors may lead to prevent metastasis and improve outcomes.
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Fig. A1The time for diagnosis and treatment.Fig. A1
